Skip to main content
Diabetes Type 2 Diabetes

Type 2 Diabetes

Editor's Choice

Management of type 2 diabetes is advancing beyond glycemic control thanks to antidiabetic drugs with cardiorenal benefits, effective weight loss agents, evolving glucose sensors, and more convenient insulin regimens.

Severe acute renal failure and AKI in a patient with type 2 diabetes was accompanied by high metformin plasma concentrations and lactic acidosis. Awareness is needed for patients with AKI risk factors who are taking metformin.

Updated algorithm on how real-time and intermittently scanned CGM may be used in six clinical scenarios – T1D, T2D, new-onset diabetes, pregnancy on intensive insulin therapy, regular physical exercise, and frailty.

Episode 5: Next-generation sequencing

Emerging biomarkers in thyroid and non-small cell lung cancers

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this podcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.

This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Listen now

Case Studies

Severe acute renal failure and AKI in a patient with type 2 diabetes was accompanied by high metformin plasma concentrations and lactic acidosis. Awareness is needed for patients with AKI risk factors who are taking metformin.

Challenges in the early diagnosis and treatment of diabetic myonecrosis, an uncommon and frequently underdiagnosed complication of uncontrolled diabetes.

CPM is a rare but potentially fatal neurological condition. This case highlights the development of CPM in a patient with uncontrolled diabetes as a consequence of hyperosmolar hyperglycemia.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Discussion-based webcast addressing the causes of clinical inertia in type 2 diabetes.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Practical, expert-led digital map designed to guide treatment of type 2 diabetes with GLP‑1RAs.

Further Reading